
    
      A randomised, double-blind, placebo-controlled, incomplete block, 4-period crossover study to
      investigate the effects of 5-day repeat inhaled doses of fluticasone propionate (BID, 50-2000
      mcg) on airway responsiveness to adenosine-5'-monophosphate (AMP) challenge when delivered
      after the last dose in mild asthmatic subjects
    
  